Recombinant Human Plaur Protein，His

Plaur, or Plasminogen Activator, Urokinase Receptor, is a crucial protein involved in the regulation of extracellular matrix remodeling and cell migration through its role in the plasminogen activation system. It binds to urokinase-type plasminogen activator (uPA), facilitating the conversion of plasminogen to plasmin, an essential enzyme for the degradation of fibrin and other components of the extracellular matrix. This function is particularly significant in physiological processes such as wound healing, tissue repair, and embryogenesis. However, aberrant expression or activity of Plaur has been implicated in various pathological conditions, including cancer metastasis, acute and chronic inflammatory diseases, and cardiovascular disorders. Consequently, the study of recombinant Plaur protein has gained significant attention as researchers aim to elucidate its molecular mechanisms, potential therapeutic targets, and broader implications in health and disease. By producing recombinant Plaur, scientists can investigate its structural properties, binding interactions, and functional roles in various biological contexts. Moreover, understanding its interactions with other proteins and pathways may lead to novel interventions for diseases characterized by dysregulated extracellular matrix dynamics. The ongoing research in this field holds the promise of providing insights into better diagnostic and therapeutic strategies that target this multifaceted protein.